A medication plan is more than a starting prescription. Rewind Bar advertises a supervised program with recurring visits; confirm what those visits actually measure and how decisions are made if the plan changes.
Agree on what will be monitored
Ask the prescriber how they will track the health goal, side effects, other conditions, medicines and practical adherence. NIDDK says follow-up should consider both benefit and harm rather than weight change alone.
Find out who answers questions between scheduled visits and which symptoms warrant prompt clinical assessment. The right plan should account for your own medical history; an online dose schedule is not a substitute for a prescribing clinician.
Plan for changes and interruptions
Ask what happens if the medicine causes problems, is not helping, or cannot be supplied. NIDDK describes changing a medication or lifestyle plan as possible outcomes of follow-up. Do not abruptly stop or substitute a prescription without speaking with the prescriber.
If the program uses a compounded product, ask for its source and how the clinician handles FDA's stated concerns about unapproved GLP-1 products. The answer should distinguish an approved medicine from a compounded version rather than calling both FDA-approved.
Look beyond the opening term
Discuss nutrition, activity, sleep and other support that can continue after the initial program. NIDDK describes obesity care as long term; an initial package does not by itself settle maintenance decisions.
Request a written estimate for ongoing clinician visits, medication and testing, and ask how the program coordinates with your usual medical team. If pregnancy is possible or planned, raise that directly with the prescriber before continuing a weight-management medicine.